ERS statement on Philips devices: clinicians’ and patients’ perspectives, and questions to be answered

A. Simonds (London, England), W. Randerath (Solingen, Germany), R. Ersu (Ottawa, Canada), J. C. Winck (Vila Nova de Gaia, Portugal), M. Duiverman (Groningen, Netherlands), S. Schiza (Heraklion, Greece), L. Roberti (ELF, Rome, Italy)

Source: ERS webinar 2021: ERS statement on Philips devices: clinicians’ and patients’ perspectives, and questions to be answered
Number: 0

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Simonds (London, England), W. Randerath (Solingen, Germany), R. Ersu (Ottawa, Canada), J. C. Winck (Vila Nova de Gaia, Portugal), M. Duiverman (Groningen, Netherlands), S. Schiza (Heraklion, Greece), L. Roberti (ELF, Rome, Italy). ERS statement on Philips devices: clinicians’ and patients’ perspectives, and questions to be answered. ERS webinar 2021: ERS statement on Philips devices: clinicians’ and patients’ perspectives, and questions to be answered

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: